Skip to main content
FinSpry Logo
FinSpry
TAK logo
TAK
(NYSE)
Takeda Pharmaceutical Company Limited
$17.63-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Takeda Pharmaceutical Company (TAK) Stock Price & Financial Analysis

Takeda Pharmaceutical Company Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$17.48 - $17.66
52-Week High$18.90
52-Week Low$12.99
Open$17.50
Volume3.14M
Average Volume (3M)3.79M
Market Cap55.01B
Shares Outstanding3.16B
P/E Ratio (TTM)48.08
Forward P/E36.44
Price to Sales (P/S)1.89
Price to Book (P/B)1.72
EV/EBITDA10.46
Revenue (TTM)29.13B
Net Income (TTM)1.15B
Free Cash Flow (TTM)4.85B
EPS (TTM)$0.36
Profit Margin3.94%
Operating Margin11.90%
Return on Equity (ROE)3.58%
Debt to Equity0.88
50-Day MA$16.37
200-Day MA$16.37
52-Week Change20.84%
Annual Dividend$0.97
Dividend Yield5.56%
Payout Ratio200.00%
Last Dividend Ex-DateMar 31, 2027

Frequently Asked Questions About Takeda Pharmaceutical Company

What is the current stock price for TAK?

As of the latest trading session, TAK stock trades at $17.63. The 52-week range is $12.99–$18.90, with a day range of $17.48–$17.66.

What is the P/E ratio for TAK?

Takeda Pharmaceutical Company's trailing P/E ratio is 48.1, meaning investors pay $48.1 for every $1 of annual earnings. The forward P/E is 36.4, reflecting analyst expectations for future earnings. Takeda Pharmaceutical Company operates in the Healthcare sector.

Does TAK pay dividends?

Yes, Takeda Pharmaceutical Company pays a 5.56% annual dividend yield ($0.97 per share). The payout ratio is 200.0%. The last ex-dividend date was 2027-03-31.

What do analysts recommend for TAK?

Based on 1 analyst, the consensus for TAK is Buy.

What is the market cap of TAK?

Takeda Pharmaceutical Company's market capitalization is $55.71B, classifying it as a large-cap company. Takeda Pharmaceutical Company operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.